IBDEI2Q3 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,43407,1,4,0)
 ;;=4^I25.110
 ;;^UTILITY(U,$J,358.3,43407,2)
 ;;=^5007108
 ;;^UTILITY(U,$J,358.3,43408,0)
 ;;=F17.219^^158^2107^46
 ;;^UTILITY(U,$J,358.3,43408,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43408,1,3,0)
 ;;=3^Nicotine Dependence,Cigarettes
 ;;^UTILITY(U,$J,358.3,43408,1,4,0)
 ;;=4^F17.219
 ;;^UTILITY(U,$J,358.3,43408,2)
 ;;=^5003369
 ;;^UTILITY(U,$J,358.3,43409,0)
 ;;=F17.299^^158^2107^47
 ;;^UTILITY(U,$J,358.3,43409,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43409,1,3,0)
 ;;=3^Nicotine Dependence,E-Cigarettes
 ;;^UTILITY(U,$J,358.3,43409,1,4,0)
 ;;=4^F17.299
 ;;^UTILITY(U,$J,358.3,43409,2)
 ;;=^5003379
 ;;^UTILITY(U,$J,358.3,43410,0)
 ;;=Z51.5^^158^2107^55
 ;;^UTILITY(U,$J,358.3,43410,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43410,1,3,0)
 ;;=3^Palliative Care Encounter
 ;;^UTILITY(U,$J,358.3,43410,1,4,0)
 ;;=4^Z51.5
 ;;^UTILITY(U,$J,358.3,43410,2)
 ;;=^5063063
 ;;^UTILITY(U,$J,358.3,43411,0)
 ;;=Z23.^^158^2107^22
 ;;^UTILITY(U,$J,358.3,43411,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43411,1,3,0)
 ;;=3^Encounter for Immunization(s)
 ;;^UTILITY(U,$J,358.3,43411,1,4,0)
 ;;=4^Z23.
 ;;^UTILITY(U,$J,358.3,43411,2)
 ;;=^5062795
 ;;^UTILITY(U,$J,358.3,43412,0)
 ;;=E11.65^^158^2107^16
 ;;^UTILITY(U,$J,358.3,43412,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43412,1,3,0)
 ;;=3^DM Type 2 Uncontrolled w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,43412,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,43412,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,43413,0)
 ;;=E11.649^^158^2107^17
 ;;^UTILITY(U,$J,358.3,43413,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43413,1,3,0)
 ;;=3^DM Type 2 Uncontrolled w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,43413,1,4,0)
 ;;=4^E11.649
 ;;^UTILITY(U,$J,358.3,43413,2)
 ;;=^5002662
 ;;^UTILITY(U,$J,358.3,43414,0)
 ;;=I16.1^^158^2107^35
 ;;^UTILITY(U,$J,358.3,43414,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43414,1,3,0)
 ;;=3^Hypertensive Emergency
 ;;^UTILITY(U,$J,358.3,43414,1,4,0)
 ;;=4^I16.1
 ;;^UTILITY(U,$J,358.3,43414,2)
 ;;=^8204721
 ;;^UTILITY(U,$J,358.3,43415,0)
 ;;=I16.9^^158^2107^34
 ;;^UTILITY(U,$J,358.3,43415,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43415,1,3,0)
 ;;=3^Hypertensive Crisis,Unspec
 ;;^UTILITY(U,$J,358.3,43415,1,4,0)
 ;;=4^I16.9
 ;;^UTILITY(U,$J,358.3,43415,2)
 ;;=^5138600
 ;;^UTILITY(U,$J,358.3,43416,0)
 ;;=I16.0^^158^2107^36
 ;;^UTILITY(U,$J,358.3,43416,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43416,1,3,0)
 ;;=3^Hypertensive Urgency
 ;;^UTILITY(U,$J,358.3,43416,1,4,0)
 ;;=4^I16.0
 ;;^UTILITY(U,$J,358.3,43416,2)
 ;;=^8133013
 ;;^UTILITY(U,$J,358.3,43417,0)
 ;;=R97.20^^158^2107^21
 ;;^UTILITY(U,$J,358.3,43417,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43417,1,3,0)
 ;;=3^Elevated PSA
 ;;^UTILITY(U,$J,358.3,43417,1,4,0)
 ;;=4^R97.20
 ;;^UTILITY(U,$J,358.3,43417,2)
 ;;=^334262
 ;;^UTILITY(U,$J,358.3,43418,0)
 ;;=R82.79^^158^2107^1
 ;;^UTILITY(U,$J,358.3,43418,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43418,1,3,0)
 ;;=3^Abnormal Findings Microbiological Urine Exam,Other
 ;;^UTILITY(U,$J,358.3,43418,1,4,0)
 ;;=4^R82.79
 ;;^UTILITY(U,$J,358.3,43418,2)
 ;;=^5139222
 ;;^UTILITY(U,$J,358.3,43419,0)
 ;;=R73.03^^158^2107^57
 ;;^UTILITY(U,$J,358.3,43419,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43419,1,3,0)
 ;;=3^Pre-Diabetes
 ;;^UTILITY(U,$J,358.3,43419,1,4,0)
 ;;=4^R73.03
 ;;^UTILITY(U,$J,358.3,43419,2)
 ;;=^8295662
